ELVN Earnings

Quarterly EPS
$-0.48
Q3 2024
$-0.46
Q4 2024
$-0.57
Q1 2025
$-0.49
Q2 2025
$-0.32
Q3 2025
$-0.48
Q4 2025
$-0.38
Q1 2026
$-0.49
Q2 2026
Latest RevenueN/A
Latest Net Income-32485000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.490-32485000+0.0%
Q1 2026-$0.380-23627000+33.3%
Q4 2025-$0.480-29667000-4.3%
Q3 2025-$0.320-20148000+33.3%
Q2 2025-$0.490-25335000-19.5%
Q1 2025-$0.570-28544000-5.6%
Q4 2024-$0.460-23180000+0.0%
Q3 2024-$0.480-23156000+5.9%
Q2 2024-$0.410-19950000
Q1 2024-$0.540-22738000
Q4 2023-$0.460-19370000
Q3 2023-$0.510-20769000
Enliven Therapeutics (ELVN) — Earnings